Local and systemic thrombolytic therapy for acute deep venous thrombosis

Netherlands Journal of Medicine

Volumn 63, Issue 3, 2005, Pages 81-90

  Janssen, M C H ^a   Wollersheim, H ^a   Schultze Kool, L J ^a   Thien, Th ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; ANTICOAGULANT AGENT; COUMARIN; FIBRINOLYTIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; RETEPLASE; STREPTOKINASE; TENECTEPLASE; UROKINASE;

ANTICOAGULANT THERAPY; BLEEDING; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CLOTHING; COMPRESSION THERAPY; COST; DEEP VEIN THROMBOSIS; DRUG DELIVERY SYSTEM; FIBRINOLYTIC THERAPY; GASTROINTESTINAL HEMORRHAGE; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; LEG THROMBOSIS; LOCAL THERAPY; MINIMAL RESIDUAL DISEASE; PATHOPHYSIOLOGY; POSTTHROMBOSIS SYNDROME; RETROPERITONEAL HEMORRHAGE; REVIEW; RISK ASSESSMENT; SAFETY; STANDARD; STENOSIS; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW; SYSTEMIC THERAPY; THROMBECTOMY; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME; VEIN CATHETERIZATION; VEIN INJURY; VEIN VALVE;

ACUTE DISEASE; CATHETERIZATION, PERIPHERAL; FIBRINOLYTIC AGENTS; HUMANS; THROMBECTOMY; THROMBOLYTIC THERAPY; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 15544370832     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (82)

1. Heit JA, Silverstein MD, Mohr DN, et al. The epidemiology of venous thromboembolism in the community. Thromb Haemost 2001;86:452-63.
2. Nordstrom M, Lindblad B, Bergqvist D, Kjellstrom T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med 1992;232:155-60.
3. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ III. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998;158:585-93.
4. Hyers TM, Agnelli C, Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease. Chest 2001;119:S176-93.
5. Janssen MC, Novakova JR, Verbruggen H, Wollersheim H, Thien T. New developments in the treatment of deep venous thrombosis. Neth J Med 1997;50:36-45.
6. Kearon C. Natural history of venous thromboembolism. Circulation 2003;107:122-30.
7. Kahn SR, Ginsberg JS. The post-thrombotic syndrome: current knowledge, controversies, and directions for future research. Blood Rev 2002;16:155-65.
8. Allan JC. The micro-circulation of the skin of the normal leg, in varicose veins and in the post-thrombotic syndrome. S Afr J Surg 1972;10:29-40.
9. Bernardi E, Prandoni P. The post-thrombotic syndrome. Curr Opin Pulm Med 2000;6:335-42.
10. Kahn SR, Ginsberg JS. Relationship between deep venous thrombosis and the postthrombotic syndrome. Arch Intern Med 2004;164:17-26.
11. Haenen JH, Janssen MC, van Langen H, et al. Duplex ultrasound in the hemodynamic evaluation of the late sequelae of deep venous thrombosis. J Vasc Surg 1998;27:472-8.
12. Markel A, Manzo RA, Bergelin RO, Strandness DE Jr. Incidence and time of occurrence of valvular incompetence following deep vein thrombosis. Wien Med Wochenschr 1994;144:216-20.
13. Van Haarst EP, Liasis N, van Ramshorst B, Moll FL. The development of valvular incompetence after deep vein thrombosis: a 7 year follow-up study with duplex scanning. Eur J Vasc Endovasc Surg 1996;12:295-9.
14. Van Ramshorst B, van Bemmelen PS, Hoeneveld H, Eikelboom BC. The development of valvular incompetence after deep vein thrombosis: a follow-up study with duplex scanning. J Vasc Surg 1994;19:1059-66.
15. Leizorovicz A. Long-term consequences of deep vein thrombosis. Haemostasis 1998;28:1-7.
16. Prandoni P, Lensing AW, Prins MH, Bagatella P, Scudeller A, Girolami A. Which is the outcome of the post-thrombotic syndrome? Thromb Haemost 1999;82:1358.
17. Leizorovicz A, Simonneau C, Decousus H, Boissel JP. Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: a meta-analysis. BMJ 1994;309:299-304.
18. Green D, Hirsh J, Heit J, Prins M, Davidson B, Lensing AW. Low molecular weight heparin: a critical analysis of clinical trials. Pharmacol Rev 1994;46:89-109.
19. Lensing AW, Prins MH, Davidson BL, Hirsh J. Treatment of deep venous thrombosis with low-molecular-weight heparins. A meta-analysis. Arch Intern Med 1995;155:601-7.
20. Hirsh J. Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of deep venous thrombosis. Semin Hematol 1997:34:20-5.
21. Krishnan JA, Segal JB, Streiff MB, et al. Treatment of venous thromboembolism with low-molecular-weight heparin: a synthesis of the evidence published in systematic literature reviews. Respir Med 2004;98:376-86.
22. Leizorovicz A. Comparison of the efficacy and safety of low molecular weight heparins and unfractionated heparin in the initial treatment of deep venous thrombosis. An updated meta-analysis. Drugs 1996;52:30-7.
23. Brandjes DP, Buller HR, Heijboer H, et al. Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet 1997;349:759-62.
24. Comerota AJ, Aldridge SC. Thrombolytic therapy for deep venous thrombosis: a clinical review. Can J Surg 1993;36:359-64.
25. Goldhaber SZ. Management of deep venous thrombosis and pulmonary embolism. Clin Cornerstone 2000;2:47-58.
26. Arnesen H, Heilo A, Jakobsen E, Ly B, Skaga E. A prospective study of streptokinase and heparin in the treatment of deep vein thrombosis. Acta Med Scand 1978;203:457-63.
27. Browse NL, Thomas ML, Pim HP. Streptokinase and deep vein thrombosis. BMJ 1968;3:717-20.
28. Duckert F, Muller G, Nyman D. Treatment of deep vein thrombosis with streptokinase. BMJ 1975;1:479-81.
29. Elliot MS, Immelman EJ, Jeffery P. A comparative randomized trial of heparin versus streptokinase in the treatment of acute proximal venous thrombosis: an interim report of a prospective trial. Br J Surg 1979;66:838-43.
30. Goldhaber SZ, Meyerovitz MF, Green D, Vogelzang RL, Citrin F, Heit J. Randomized controlled trial of tissue plasminogen activator in proximal deep venous thrombosis. Am J Med 1990;88;235-40.
31. Goldhaber SZ, Polak JF, Feldstein ML, Meyerovitz MF, Creager MA. Efficacy and safety of repeated boluses of urokinase in the treatment of deep venous thrombosis. Am J Cardiol 1994;73:75-9.
32. Jeffrey P, Immelman EJ, Amoore J. Treatment of deep vein thrombosis with heparin or streptokinase: long-term venous function assessment [Abstract]. Proc Sec Int Vasc Symp London 1986.
33. Kakkar VV, Flanc C, Howe CT, O'Shea M, Flute PT. Treatment of deep vein thrombosis. A trial of heparin, streptokinase, and arvin. BMJ 1969;1:806-10.
34. Marder VJ, Soulen RL, Atichartakarn V. Quantitative venographic assessment of deep vein thrombosis in the evaluation of streptokinase and heparin treatment. J Lab Clin Med 1977;89:1018-29.
35. Porter JM, Seaman AJ, Common HH, Rosch J, Eidemiller LR, Calhoun AD. Comparison of heparin and streptokinase in the treatment of venous thrombosis. Am Surg 1975;41:511-9.
36. Robertson B, Nilson IM, Nylander C. Value of streptokinase and heparin in treatment of acute deep vein thrombosis. Acta Chir Scand 1968;134:203-8.
37. Robertson B, Nilsson IM, Nylander C. Thrombolytic effect of streptokinase as evaluated by phlebograhy of deep venous thrombi of the leg. Acta Chir Scand 1970:136:173-80.
38. Schulman S, Granqvist S, Juhlin-Dannfelt A. Long-term sequelae of calf vein thrombosis treated with heparin of low-dose streptokinase. Acta Med Scand 1986;219:349-57.
39. Schweizer J, Kirch W, Koch R, et al. Short- and long-term results after thrombolytic treatment of deep venous thrombosis. J Am Coll Cardiol 2000;36:1336-43.
40. Tsapogas MJ, Peabody RA, Wu KT. Controlled study of thrombolytic therapy in deep vein thrombosis. Surgery 1973;74:973-84.
41. Turpie AG, Levine MN, Hirsh J, Ginsberg JS, Cruickshank M, Jay R. Tissue plasminogen activator (rt-PA) vs heparin in deep vein thrombosis: results of a randomized trial. Chest 1990;97:S172-5.
42. Watz R, Savidge GF. Rapid thrombolysis and preservation of valvular venous function in high deep vein thrombosis. Acta Med Scand 1979;205:293-8.
43. Elsharawy M, Elzayat E. Early results of thrombolysis vs anticoagulation in iliofemoral venous thrombosis. A randomised clinical trial. Eur J Vasc Endovasc Surg 2002;24:209-14.
44. Arnesen H, Hoiseth A, Ly B. Streptokinase of heparin in the treatment of deep vein thrombosis. Follow-up results of a prospective study. Acta Med Scand 1982;211:65-8.
45. Bieger R, Boekhout-Mussert RJ, Hohmann F, Loeliger EA. Is streptokinase useful in the treatment of deep vein thrombosis? Acta Med Scand 1976;199:81-8.
46. Common HH, Seaman AJ, Rosch J, Porter JM, Dotter CT. Deep vein thrombosis treated with streptokinase or heparin. Follow-up of a randomized study. Angiology 1976;27:645-54.
47. Johansson L, Nylander C, Hedner U, Nilsson IM. Comparison of streptokinase with beparin: late results in the treatment of deep venous thrombosis. Acta Med Scand 1979;206:93-8.
48. Kakkar VV, Howe CT, Laws JW, Flanc C. Late results of treatment of deep vein thrombosis. BMJ l969;1:810-1.
49. Theiss W, Wirtzfeld A, Fink U, Maubach P. The success rate of fibrinolytic therapy in fresh and old thrombosis of the iliac and femoral veins. Angiology 1983;34:61-9.
50. Schweizer J, Nierade A, Florek HJ, Altmann E. Ultrasound angiography in diagnosis of deep venous thrombosis and post-thrombotic syndrome. A prospective comparative study. Ultraschall Med 1997;18:88-90.
51. Hirsh J, Lensing AW. Thrombolytic therapy for deep vein thrombosis. Int Angiol 1996;5:S22-5.
52. Markel A, Manzo RA, Strandness DE Jr. The potential role of thrombolytic therapy in venous thrombosis. Arch Intern Med 1992;152:1265-7.
53. Grossman C, McPherson S. Safety and efficacy of catheter-directed thrombolysis for iliofemoral venous thrombosis. Am J Roentgenol 1999;172:667-72.
54. Baldwin ZK, Comerota AJ, Schwartz LB. Catheter-directed thrombolysis for deep venous thrombosis. Vasc Endovasc Surg 2004;38:1-9.
55. Burkart DJ, Borsa JJ, Anthony JP, Thurlo SR. Thrombolysis of occluded peripheral arteries and veins with tenecteplase: a pilot study. J Vasc Interv Radiol 2002;13:1099-102.
56. Castaneda F, Li R, Young K, Swischuk JL, Smouse B, Brady T. Catheter-directed thrombolysis in deep venous thrombosis with use of reteplase: immediate results and complications from a pilot study. J Vasc Interv Radiol 2002;13:577-80.
57. Cho YP, Jang HJ, Lee DH, et al. Deep venous thrombosis associated with protein C and/or S deficiency: management with catheter-directed thrombolysis. Br J Radiol 2003;76:380-4.
58. Comerota AJ, Kagan SA. Catheter-directed thrombolysis for the treatment of acute iliofemoral deep venous thrombosis. Phlebology 2000;15:149-55.
59. Grunwald MR. Hofmann LV. Comparison of urokinase, alteplase, and reteplase for catheter-directed thrombolysis of deep venous thrombosis. J Vasc Interv Radiol 2004;15:347-52.
60. Mewissen MW, Seabrook GR, Meissner MH, Cynamon J, Labropoulos N, Haughton SH. Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a rational multicenter registry. Radiology 1999;211:39-49.
61. Palombo D, Porta C, Brustia P, et al. Loco-regional thrombolysis in deep venous thrombosis. Phlebologie 1993;46:293-302.
62. Raju S, Fountain T, McPherson SH. Catheter-directed thrombolysis for deep venous thrombosis. J Miss State Med Assoc 1998;39:81-4.
63. Semba CP, Dake MD. Catheter-directed thrombolysis for iliofemoral venous thrombosis. Semin Vasc Surg 1996;9:26-33.
64. AbuRahma AF, Perkins SE, Wulu JT, Ng HK. Iliofemoral deep vein thrombosis: conventional therapy versus lysis and percutaneous transluminal angioplasty and stenting. Ann Surg 2001;233:752-60.
65. Bjarnason H, Kruse JR, Asinger DA, et al. Iliofemoral deep venous thrombosis: safety and efficacy outcome during 5 years of catheter-directed thrombolytic therapy. J Vasc Interv Radiol 1997;8:405-18.
66. Emanuelli C, Segramora V, Frigerio C. Selected strategies in venous thromboembolism: local thrombolytic treatment and caval filters. Haematologica 1995;80:84-6.
67. Horne MK, III, Mayo DJ, Cannon RO, III, Chen CC, Shawker TH, Chang R. Intraclot recombinant tissue plasminogen activator in the treatment of deep venous thrombosis of the lower and upper extremities. Am J Med 2000;108:251-5.
68. Molina JE, Hunter DW, Yedlicka JW. Thrombolytic therapy for iliofemoral venous thrombosis. Vasc Surg 1992;26:630-7.
69. Verhaeghe R, Stockx L, Lacroix H, Vermylen J, Baert AL. Catheter-directed lysis of iliofemoral vein thrombosis with use of rt-PA. Eur Radiol 1997;7:996-1001.
70. Meissner MH. Thrombolytic therapy for acute deep vein thrombosis and the venous registry. Rev Cardiovasc Med 2002;3(suppl 2):S53-60.
71. Comerota AJ. Quality-of-life improvement using thrombolytic therapy for iliofemoral deep venous thrombosis. Rev Cardiovasc Med 2002;3(suppl 2):S61-7.
72. Elliott G. Thrombolytic therapy for venous thromboembolism. Curr Opin Hematol 1999;6:304-8.
73. Ouriel K, Gray B, Clair DG, Olin J. Complications associated with the use of urokinase and recombinant tissue plasminogen activator for catheter-directed peripheral arterial and venous thrombolysis. J Vasc Interv Radiol 2000;11:295-8.
74. Sharafuddin MJ, Sun S, Hoballah JJ, Youness FM, Sharp WJ, Roh BS. Endovascular management of venous thrombotic and occlusive diseases of the lower extremities. J Vasc Interv Radiol 2003;14:405-23.
75. Morgan R, Belli AM. Percutaneous thrombectomy: a review. Eur Radiol 2002;12:205-17.
76. Frisoli JK, Sze D. Mechanical thrombectomy for the treatment of lower extremity deep vein thrombosis. Tech Vasc Interv Radiol 2003;6:49-52.
77. Vedantham S, Vesely TM, Parti N, Darcy M, Hovsepian DM, Picus D. Lower extremity venous thrombolysis with adjunctive mechanical thrombectomy. J Vasc Interv Radiol 2002;13:1001-8.
78. Delomez M, Beregi JP, Willoteaux S, et al. Mechanical thrombectomy in patients with deep venous thrombosis. Cardiovasc Intervent Radiol 2001;24:42-8.
79. Kasirajan K, Gray B, Ouriel K. Percutaneous AngioJet thrombectomy in the management of extensive deep venous thrombosis. J Vasc Interv Radiol 2001;12:179-85.
80. Vedantham S, Vesely TM, Sicard GA, et al. Pharmacomechanical thrombolysis and early stent placement for iliofemoral deep vein thrombosis. J Vasc Interv Radiol 2004;15:565-74.
81. McLennan G, Trerotola SO, Davidson D, et al. The effects of a mechanical thrombolytic device on normal canine vein valves. J Vasc Interv Radiol 2001;12:89-94.
82. Trerotola SO, McLennan G, Davidson D, et al. Preclinical in vivo testing of the Arrow-Trerotola percutaneous thrombolytic device for venous thrombosis. J Vasc Interv Radiol 2001;12:95-103.